Improvement in angina pectoris with alpha adrenoceptor blockade

Area of Science:

• Cardiology
• Pharmacology

Background:

• Chronic stable angina is a common condition often managed with beta blockers and nitrates.
• The role of alpha 1 adrenoceptor antagonists in angina management requires further investigation.

Purpose of the Study:

• To evaluate the effects of indoramin, a selective alpha 1 adrenoceptor antagonist, on exercise tolerance in patients with chronic stable angina.

Main Methods:

• A randomized, double-blind, crossover study involving 15 patients with stable angina.
• Patients continued their existing beta blocker and nitrate therapy.
• Indoramin was administered at 25 mg three times daily.

Main Results:

• Indoramin significantly prolonged exercise duration and increased oxygen consumption.
• A reduction in ST segment depression during exercise was observed.
• Maximal double product remained unchanged.

Conclusions:

• Alpha 1 adrenoceptor blockade with indoramin may offer additional benefits for patients with stable angina already on beta blockers and nitrates.
• Indoramin demonstrated a favorable safety profile in this patient group.